Shareholder Weng Zhanguo of Shanxi C&Y Pharmaceutical Group (stock code: 300254.SZ) plans to reduce his shareholding by no more than 3%.
Qiandian Pharmaceutical (300254.SZ) announced that the company's shareholder, Weng Zhanguo, plans to reduce his shares from November 13, 2025 to 2...
Shanxi C&Y Pharmaceutical Group (300254.SZ) announced that the company's shareholder, Weng Zhanguo, plans to reduce his holdings of the company's shares through centralized bidding and block trading from November 13, 2025 to February 12, 2026, with a maximum of 7.6831 million shares (not exceeding 3% of the total share capital of the company).
Related Articles

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


